Abstract
The fight against human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has made significant progress over the past decades, yet sustainable funding remains a critical challenge. Despite advances in medical treatments and prevention methods, the financial resources needed to combat the epidemic consistently face uncertainties and shortfalls. As of 2023, approximately 37.7 million people are living with HIV/AIDS globally, with 1.5 million new infections reported annually. Sub-Saharan Africa remains the hardest-hit region, accounting for 67% of the global HIV burden. This paper examines the current state of HIV/AIDS funding, identifying key gaps and challenges in maintaining adequate financial resources. It highlights the effects of funding fluctuations on treatment accessibility, prevention programs, and research, stressing the urgent need for diversified and innovative financing mechanisms. The paper offers actionable insights into sustainable funding strategies by analyzing successful models such as public-private partnerships and social impact bonds. This review aims to inform policymakers, stakeholders, and the global community about the financial barriers to HIV/AIDS management and advocate for coordinated efforts to secure stable funding pathways. Ensuring consistent financial support is vital to preserving hard-won progress, expanding access to care, and achieving the ultimate goal of an AIDS-free generation.